Cargando…
Anticoagulation in pulmonary arterial hypertension: Contemporary data from COMPERA registry
The use of anticoagulant therapy in patients with pulmonary arterial hypertension (PAH) has been controversial for decades. Recommendations for anticoagulation in these patients are often derived from small, retrospective, and single centre studies without any placebo-controlled randomized study. Fu...
Autor principal: | Said, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bloomsbury Qatar Foundation Journals
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220434/ https://www.ncbi.nlm.nih.gov/pubmed/25405178 http://dx.doi.org/10.5339/gcsp.2014.25 |
Ejemplares similares
-
Macitentan in pulmonary arterial hypertension: The SERAPHIN trial
por: Said, Karim
Publicado: (2014) -
AMBITION: An important piece in the therapeutic puzzle of pulmonary arterial hypertension
por: Said, Karim
Publicado: (2015) -
TAVR update: Contemporary data from the UK TAVI and US TVT registries
por: Suradi, Hussam S., et al.
Publicado: (2015) -
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry
por: Hoeper, Marius M., et al.
Publicado: (2022) -
Takotsubo cardiomyopathy: A potentially serious trap (Data from the International Takotsubo Cardiomyopathy Registry)
por: Wagdy, Kerolos, et al.
Publicado: (2015)